CN110025719A - A kind of Chinese medicinal formulae and preparation method thereof for treating lung cancer - Google Patents
A kind of Chinese medicinal formulae and preparation method thereof for treating lung cancer Download PDFInfo
- Publication number
- CN110025719A CN110025719A CN201910343636.9A CN201910343636A CN110025719A CN 110025719 A CN110025719 A CN 110025719A CN 201910343636 A CN201910343636 A CN 201910343636A CN 110025719 A CN110025719 A CN 110025719A
- Authority
- CN
- China
- Prior art keywords
- parts
- lung cancer
- chinese medicinal
- medicinal formulae
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010058467 Lung neoplasm malignant Diseases 0.000 title claims abstract description 40
- 201000005202 lung cancer Diseases 0.000 title claims abstract description 40
- 208000020816 lung neoplasm Diseases 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000003814 drug Substances 0.000 claims abstract description 22
- 241000432824 Asparagus densiflorus Species 0.000 claims abstract description 20
- 235000013717 Houttuynia Nutrition 0.000 claims abstract description 16
- 235000017847 Anchusa officinalis Nutrition 0.000 claims abstract description 15
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 15
- 240000004050 Pentaglottis sempervirens Species 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 240000005001 Paeonia suffruticosa Species 0.000 claims abstract description 13
- 235000003889 Paeonia suffruticosa Nutrition 0.000 claims abstract description 13
- 238000001914 filtration Methods 0.000 claims abstract description 12
- 239000000706 filtrate Substances 0.000 claims abstract description 11
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 8
- 238000005303 weighing Methods 0.000 claims abstract description 3
- 240000000691 Houttuynia cordata Species 0.000 claims abstract 4
- 238000000034 method Methods 0.000 claims description 5
- 235000014102 seafood Nutrition 0.000 claims description 3
- 235000015278 beef Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 18
- 235000013350 formula milk Nutrition 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 210000004072 lung Anatomy 0.000 description 17
- 241000758769 Houttuynia Species 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 10
- 210000000038 chest Anatomy 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 8
- 201000011510 cancer Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 6
- 230000000259 anti-tumor effect Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 208000002151 Pleural effusion Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 230000002980 postoperative effect Effects 0.000 description 5
- 238000002604 ultrasonography Methods 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 241000521257 Hydrops Species 0.000 description 4
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000003516 pericardium Anatomy 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 244000157790 Buglossoides arvense Species 0.000 description 3
- 235000004256 Buglossoides arvense Nutrition 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000242 pagocytic effect Effects 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000002620 vena cava superior Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 241000432767 Asparagus setaceus Species 0.000 description 2
- 206010048962 Brain oedema Diseases 0.000 description 2
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010048612 Hydrothorax Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000007433 Lymphatic Metastasis Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 208000006752 brain edema Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 210000005015 mediastinal lymph node Anatomy 0.000 description 2
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 241001412627 Adenophora liliifolia Species 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003598 Atelectasis Diseases 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 208000006332 Choriocarcinoma Diseases 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000005125 Invasive Hydatidiform Mole Diseases 0.000 description 1
- 241000801118 Lepidium Species 0.000 description 1
- 208000032923 Lobar pneumonia Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000005228 Pericardial Effusion Diseases 0.000 description 1
- 241001522129 Pinellia Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 102100038567 Properdin Human genes 0.000 description 1
- 108010005642 Properdin Proteins 0.000 description 1
- 208000007123 Pulmonary Atelectasis Diseases 0.000 description 1
- 206010056342 Pulmonary mass Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000001370 mediastinum Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 201000003144 pneumothorax Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 210000004116 schwann cell Anatomy 0.000 description 1
- HPPWMWCITPGPKK-UHFFFAOYSA-M sodium;1-hydroxy-3-oxododecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCC(=O)CC(O)S([O-])(=O)=O HPPWMWCITPGPKK-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000008732 thymoma Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 208000025301 tympanitis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of Chinese medicinal formulaes and preparation method thereof for treating lung cancer, drug price in order to solve the problems, such as to treat lung cancer in the prior art is high, therapeutic effect is poor, proposes a kind of technical solution are as follows: a kind of Chinese medicinal formulae for treating lung cancer includes following component according to parts by weight: double 28-32 parts of grass of dragon, open country 28-32 parts of Radix Angelicae Sinensis, 18-22 parts of Radix Rehmanniae, 10-14 parts of asparagus fern, 18-22 parts of cordate houttuynia, 10-14 parts of the root bark of tree peony, 10-14 parts of alkanet；Preparation method includes the following steps: S1: weighing the medicinal material of specified amount and successively puts into medicinal material in casserole；S2: clear water is added in casserole and decocts 1 hour；Filter residue and filtrate are collected in filtering；S3: clear water is added into filter residue again and decocts 1 hour；Filtrate is collected in filtering；S4: merge the filtrate being obtained by filtration twice, obtain Chinese medicinal formulae.Present component is simple, cheap and curative effect is preferable.
Description
Technical field
The present invention relates to a kind of Chinese medicinal formulaes and preparation method thereof, and in particular to treats Chinese medicinal formulae and its preparation of lung cancer
Method.
Background technique
According to the statistics of the World Health Organization, the annual pathogenesis of cancer number about 10,000,000 in the whole world, dead about 7,000,000 people, oneself at
For the second killer of the mankind for being only second to cardiovascular disease.The death rate of lung cancer is first of cancer, and clinically lung cancer can be divided into cellule
Lung cancer (SCLC) and non-small cell type lung cancer (NSCLC), wherein NSCLC includes gland cancer, squamous carcinoma and maxicell lung cancer, accounts for about lung cancer
The 80-85% of sum, due to lacking early diagnosis and effective treatment means, 5 years survival rates of NSCLC are less than 15%.Although putting
Chemotherapy is widely used in NSCLC, and since long-term survival rate is low, toxic side effect is big, and curative effect is simultaneously unsatisfactory.
At present in the chemotherapeutics of the most direct kill tumour cell of clinical application, since its cytotoxicity and multiple medicine are resistance to
Pharmacological property makes its development encounter bottleneck, and nearly stage difficulty has breakthrough.Treatment of Lung Cancer with Chinese Medicine clinical experience proves that lung cancer is postoperative to match
Chinese medicine treatment is closed, postoperative rehabilitation can be accelerated, improves operative effect, delays even to contain useless cancer recurrence and transfer, for extending
Patient survival improves its quality of life and has preferable effect.The drug variety of Current therapeutic lung cancer is various, however cure rate
The shortcomings that not high, and that there is drug prices is higher, and patient wants Long-term taking medicine.
If publication date is on July 21st, 2004, the Chinese patent of Publication No. CN1158091C, which proposes, a kind of treats lung
The Chinese medicine composition of cancer, costly, and the Chinese medicine composition needs the drug prices such as cordyceps sinensis used, the root of straight ladybell in the invention
It takes for a long time just effective.
Summary of the invention
It is an object of the invention to overcome the above deficiencies in the existing technologies, and provide it is a kind of simple, conveniently, treatment
The Chinese medicinal formulae for the treatment of lung cancer and preparation method thereof that effect is good, medicine valence is low.
Technical solution used by the present invention solves the above problems is: the Chinese medicinal formulae of the treatment lung cancer includes by weight
The following component of number meter: double 28-32 parts of grass of dragon, wild 28-32 parts of Radix Angelicae Sinensis, 18-22 parts of Radix Rehmanniae, 10-14 parts of asparagus fern, cordate houttuynia 18-
22 parts, 10-14 parts of the root bark of tree peony, 10-14 parts of alkanet.
Preferably, the Chinese medicinal formulae of heretofore described treatment lung cancer includes following component according to parts by weight: double
Imperial 30 parts of grass, wild 30 parts of Radix Angelicae Sinensis, 20 parts of Radix Rehmanniae, 12 parts of asparagus fern, 20 parts of cordate houttuynia, 12 parts of the root bark of tree peony, 12 parts of alkanet.
A kind of preparation method of Chinese medicinal formulae that treating lung cancer includes the following steps:
S1: double dragon grass, the wild Radix Angelicae Sinensis, Radix Rehmanniae, asparagus fern, cordate houttuynia, the root bark of tree peony, alkanet of specified amount are weighed, and medicinal material is successively thrown
Enter into casserole；
S2: being added clear water in casserole and decoct 1 hour, and the weight of clear water is 10 times of medicinal material total weight；Filtering, collect filter residue and
Filtrate；
S3: clear water being added into filter residue again and decocts 1 hour, and the weight of clear water is 8 times of medicinal material total weight；Filtrate is collected in filtering；
S4: merge the filtrate being obtained by filtration twice, obtain Chinese medicinal formulae.
Preferably, the Chinese medicinal formulae of heretofore described treatment lung cancer avoids eating seafood and cattle and sheep in duration of medication patient
Meat.
Preferably, the dosage of the Chinese medicinal formulae of heretofore described treatment lung cancer be it is adult twice daily, each 100-
125ml。
The pharmacological action for the various bulk pharmaceutical chemicals that the present invention uses is as follows:
Double dragon grass: mainly having dispelling wind removing toxic substances, clearing away heat to and alleviating pain and other effects, can be used to treat venomous snake bite, abscess of throat and each
Kind tumour.
Wild Radix Angelicae Sinensis: bitter in taste, pungent, cold nature；Channel tropism, lung, spleen, Liver Channel；Function blood-nourishing effect, menstruation regulating, promoting blood circulation and stopping pain, ease constipation are logical
Just, irregular menstruation, dysmenorrhea, hemostasis amenorrhoea, anaemia, rheumatic arthralgia, traumatic injury, dry constipation of intestines are cured mainly.
Radix rehmanniae recen: it is cold in nature sweet in flavor, have the function of clearing heat and cooling blood, nourishing Yin and promoting production of body fluid；It can be used to treat various hot illnesss, enter
The diseases such as febrile virulent maculae, blood-head bleeding, consumption of YIN caused by febrile disease, fever due to yin deficiency and Tianjin hinder constipation；Enhance immune function: radix rehmanniae recen can be bright
The immune function of aobvious raising body, can enhance the generation of bone-marrow-derived lymphocyte antibody, increase the content of hemolysin in serum, stimulate T
Lymphocyte transformation enhances delayed allergy, promotes the function of cellular immunity at sensitized lymphocyte；Antitumor action:
The antitumor action of radix rehmanniae recen enhances that body's immunity is closely related with it, contained polysaccharide be its it is antitumor it is effective at
/ mono-, it can significantly inhibit tumour growth.
Asparagus fern: energy nourishing Yin and promoting production of body fluid, moistening lung and clearing away the heart-fire are used for dryness of the lung dry cough, cough due to consumptive disease, injury thirst, vexed insomnia, interior heat
It quenches one's thirst, the symptoms such as dry constipation of intestines, diphtheria；Antitumor: the root tuber of asparagus fern has antitumor efficacy, and asparagus fern is for acute lymphoblastic
The leucocyte dehydrogenase of type leukaemia, chronic myelocytic leukemia and Acute monocytic type leukaemic has certain suppression
Production is used, and it is able to suppress the breathing of acute lymphoblastic type leukaemic's leucocyte；Antibacterial: asparagus fern root tuber also has
Fabulous antibacterial curative effect；Asparagus fern root tuber decoction is in vitro to bacillus anthracis, A type and beta hemolytic streptococcus, corynebacterium diphtheriae, class
Corynebacterium diphtheriae, Diplococcus pneumopniae, staphylococcus aureus, Staphylococcus citreus, staphylococcus albus and hay bacillus etc. are each
Class fungi has different degrees of inhibiting effect；Delay senescence: asparagus fern root tuber has fabulous anti-oxidant and anti-aging to human body
It acts on, containing the effective component to delay senescence in the extract of asparagus fern, asparagus fern polysaccharide, which has, removes free radical and anti peroxidation of lipid
Active effect.
Cordate houttuynia: have antibacterial, anticancer, it is antiviral the effect of, control enteritis, dysentery, nephritic dropsy and mazoitis, tympanitis
Deng；The carbuncle that disappears apocenosis: cordate houttuynia is pungent cold, the carbuncle that can disappear apocenosis, can external curing pathopyretic ulcer and treatment phlegm heat heap soil or fertilizer over and around the roots
Lung, pectoralgia, the illnesss such as cough vomiting of pus and blood is stench；Enhancing is immune: the phagocytic activity of leucocyte can be enhanced in cordate houttuynia, and it is standby to improve serum
Xie Su, when treating tracheitis, sodium houttuyfonate can make patient's leucocyte obviously mention the staphylococcic phagocytic activity of white
Height, serum properdin are significantly raised.
Cortex moutan: clearing heat and cooling blood: cortex moutan acrid flavour, cold nature have the function of clearing heat and cooling blood, are usually used in treatment heat and join the army
Blood, fever due to yin deficiency, hematemesis and epistaxis, carbuncle sore tumefacting virus etc.；Anti-inflammatory analgesic: cortex moutan is commonly used to joint caused by treatment a variety of causes
Inflammation can inhibit inflammation, swelling, exudation, inhibit capillary permeability；Although its analgesic activity is not strong, in compound, can add
The effect of strong main ingredient；Tranquilizing to relieve muscle spasm: paeonol can substantially reduce spontaneous activity in mice, there is significant calm effect；Paeonol pair
Caused by acetylcholine, isolated ileum segments in guinea pigs strong contraction has significant spasmolysis；Contained Paeoniflorin is to intestinal smooth
With significant spasmolysis；Improve immunity: to rat oral gavage cortex moutan extracting solution, microscopically observation, it is seen that withered in liver
In Schwann Cells and spleen macrophage phagocytic activity enhance, from this point as can be seen that cortex moutan can enhance immunity of organisms, help to
Anti-bacterium invasion.
Asian puccoon: have effects that promoting blood circulation and cooling blood, removing toxic substances promoting eruption, can be used for treating the diseases such as macula, sore, eczema, scald；Solution
Malicious nti-freckle: Asian puccoon is salty-cold, enters Liver Channel blood system, can cooling and activating blood and promoting eruption of detoxifying, can be used to treat febrile virulent maculae, void
Very, there are the illnesss such as purple blackspot rash to heat toxin in skin；Antitumor: alkanet has chorioepithelioma and chorioadenoma certain
Curative effect；With methylene blue test tube method primary dcreening operation, alkanet has extremely slight inhibiting effect to acute lymphoblastic leukemia；Asian puccoon can be reduced
The disease incidence of spontaneous mammary carcinoma.
Compared with prior art, the present invention having the following advantages that and effect: the Chinese medicinal formulae in the present invention is only by 7 taste medium-height grass
Medicine composition, related Chinese herbal medicine is common Chinese medicine, and cheap, convenient for various regions, patient is taken.And the Chinese medicinal formulae pair
Patient has apparent curative effect, and 200 patients with lung cancer discovery of the traditional Chinese herbal decoction: 5 years survival rates of patient is taken through investigating
76%；And there is 87.6% patient symptom to be improved.
Specific embodiment
Below by embodiment, the present invention is described in further detail, following embodiment be explanation of the invention and
The invention is not limited to following embodiments.
Embodiment 1.
The Chinese medicinal formulae for the treatment of lung cancer includes following component according to parts by weight in the present embodiment: double 30 parts of dragon grass, open country
30 parts of Radix Angelicae Sinensis, 20 parts of Radix Rehmanniae, 12 parts of asparagus fern, 20 parts of cordate houttuynia, 12 parts of the root bark of tree peony, 12 parts of alkanet.
The preparation method that the Chinese medicinal formulae of lung cancer is treated in the present embodiment includes the following steps:
S1: double dragon grass, wild Radix Angelicae Sinensis, Radix Rehmanniae, asparagus fern, cordate houttuynia, the root bark of tree peony, the alkanet for weighing specified amount are put into casserole；
S2: being added clear water in casserole and decoct 1 hour, and the weight of clear water is 10 times of Chinese herbal medicine total weight；Filter residue is collected in filtering
And filtrate；
S3: clear water being added into filter residue again and decocts 1 hour, and the weight of clear water is 8 times of Chinese herbal medicine total weight；Filter is collected in filtering
Liquid；
S4: merge the filtrate being obtained by filtration twice, obtain Chinese medicinal formulae.
The dosage of the Chinese medicinal formulae of the treatment lung cancer be it is adult twice daily, each 100-125ml；The Chinese medicine for treating lung cancer
Prescription avoids eating seafood and beef and mutton in duration of medication patient.
Embodiment 2.
The present embodiment and the difference of embodiment 1 are as follows:
The Chinese medicinal formulae for the treatment of lung cancer includes following component according to parts by weight in the present embodiment: double 28 parts of dragon grass, wild Radix Angelicae Sinensis
28 parts, 18 parts of Radix Rehmanniae, 10 parts of asparagus fern, 18 parts of cordate houttuynia, 10 parts of the root bark of tree peony, 10 parts of alkanet.
Embodiment 3.
The present embodiment and the difference of embodiment 1 are as follows:
The Chinese medicinal formulae for the treatment of lung cancer includes following component according to parts by weight in the present embodiment: double 32 parts of dragon grass, wild Radix Angelicae Sinensis
32 parts, 22 parts of Radix Rehmanniae, 14 parts of asparagus fern, 22 parts of cordate houttuynia, 14 parts of the root bark of tree peony, 14 parts of alkanet.
Embodiment 4.
The present embodiment and the difference of embodiment 1 are as follows:
The Chinese medicinal formulae for the treatment of lung cancer includes following component according to parts by weight in the present embodiment: double 29 parts of dragon grass, wild Radix Angelicae Sinensis
29 parts, 19 parts of Radix Rehmanniae, 11 parts of asparagus fern, 19 parts of cordate houttuynia, 11 parts of the root bark of tree peony, 11 parts of alkanet.
Embodiment 5.
The present embodiment and the difference of embodiment 1 are as follows:
The Chinese medicinal formulae for the treatment of lung cancer includes following component according to parts by weight in the present embodiment: double 31 parts of dragon grass, wild Radix Angelicae Sinensis
31 parts, 21 parts of Radix Rehmanniae, 13 parts of asparagus fern, 21 parts of cordate houttuynia, 13 parts of the root bark of tree peony, 13 parts of alkanet.
Clinical case.
Further to investigate curative effect of medication of the present invention, clinical experimental study, all patients are carried out to the patient with lung cancer
Voluntarily receive treatment, reflection is good, no obvious toxic-side effects.The following are the typical cases of clinical test.
Patient 1: Liu, female, and 64 years old.
First visit result: CT examination shows right lung Ca with mediastinal lymph node metastasis, hydropericardium, a large amount of pleural effusions；Liver function
Show: SGPT is increased, and patient had shortness of breath, cyanotic lips at that time, and jugular vein, which is exerted, to be opened, and considers lung Ca advanced stage, and pericardium, pleural effusion influence
Lung function gives hydrothorax drainage, protect liver, the treatment such as nutrition；Patient is out of breath after treatment is clearly better, and liver function is restored substantially, gives strong
Ten Cisplatin chemotherapy are selected, in conjunction with Chinese traditional treatment；Two examine after taking traditional Chinese herbal decoction 7 days in embodiment 1.
Two examine result: patient's cough is out of breath to be clearly better, and no blood-stained sputum, tongue is red, and whitish tongue is greasy, and arteries and veins slightly counts, and checks B ultrasound
Show a small amount of hydropericardium, pleural effusion has significantly reduced, and sb.'s illness took a favorable turn；It is taken three behind traditional Chinese herbal decoction 7 days in embodiment 1 again
It examines.
Three examine result: all diseases of patient are substantially reduced, no hemoptysis；Check CT shows that pulmonary lesions have been obviously reduced, pericardium, chest
Chamber disappears substantially.
Patient 2: Shen, male, and 67 years old.
First visit result: there is blood urine in patient's five years ago, upon examination it is found that bladder cancer, gives bladder ca radical correction, it is postoperative to give bladder
Perfusion chemotherapy, stable disease, no relapse and transfer；Appearance fever, cough, phlegm are few before one week, do not treat；CT examination discovery is right
Lower lung lobar pneumonia；Blood routine shows leucocyte 15600/mm3, neutrophil leucocyte 82%；Take the Chinese medicinal decoction in embodiment 1
Two examine after agent 7 days.
Two examine result: patient's resolution of fever, and cough improves, bottom right lung can and a small amount of bubble, red tongue with thin and yellowish fur, arteries and veins omit
Number, then take behind traditional Chinese herbal decoction 7 days in embodiment 1 three and examine.
Three examine result: patient shows that right lung lesion disappears substantially without obvious cough, fever check CT, clinical cure.
Patient 3: Tan, male, and 59 years old.
First visit result: patient's five years ago is because lung Ca row upper left pneumonectomy+hilar and mediastinal lymph node cleans, during postoperative pathological shows
Break up gland cancer, it is postoperative to give 4 period of TP scheme chemotherapy；The left limb that happened suddenly before 2 days is out of strength, and headache, vomiting are checked through MRI and prompted
Lung cancer metastasis, brain edema give Whole-brain radiotherapy, and Chinese medicine are combined to treat；Two examine after taking traditional Chinese herbal decoction 7 days in embodiment 1.
Two examine result: patient's headache, vomiting disappear, left limb improvement out of strength, consider radiotherapy and Li Shui easily to impairment of yin, therefore
Former Fang Jiayong radix rehmanniae recen 30g, asparagus fern 12g；Three examine after taking again 15.
Three examine result: the left myodynamia of patient improves, and check MRI shows that brain tumor reduces, and brain edema subsides substantially.
Patient 4: Hu, male, and 72 years old.
First visit result: patient often feels left rib secret anguish over nearly 3 months, and unable to lie due to dyspnea checks diagnosis through iconography and laboratory
For exudative pleurisy, etiology unknown；Multiple row pneumothorax paracentesis, Relapse rate are refractory；X-ray film and B ultrasound show, left side
Thoracic cavity moderate hydrops；Two examine after taking traditional Chinese herbal decoction 7 days in embodiment 1.
Two examine result: the left rib secret anguish of patient disappears, and breathes with cough, shortness of breath is relieved, tongue drop, husky tongue fur, veins string, chest pa & lat
The a small amount of hydrops of X-ray film and B ultrasound display left side thoracic cavity, pachynsis pleurae sample change.
Patient 5: Mr. Wang, male, and 55 years old.
First visit result: patient's two years ago is because cough finds thymoma, and the state of an illness is still stable after giving radiotherapy；Nothing was played before 15 days
Obviously inducement gradually appears uncomfortable in chest out of breath, cannot lie down, and ultrasound diagnosis prompts large pericardial effusion, pleural effusion；Give hydropericardium
Symptom mitigates after drainage, but hydropericardium still has 50 ~ 100ml daily, to reinforce treating and Chinese medicine of seeing a doctor；It takes in embodiment 1
Traditional Chinese herbal decoction 7 days after two examine.
Two examine result: patient's hydropericardium significantly reduces, and only drains 20ml or so daily, and hydrops switched to it is yellowish
Color, it is uncomfortable in chest it is out of breath be clearly better, tongue vein as before, therefore original side in lepidium seed be kept to 15g, go rhizoma alismatis, the tuber of pinellia processed to take 7 doses again；It takes
Three examine behind traditional Chinese herbal decoction 7 days in embodiment 1.
Three examine result: patient is without uncomfortable in chest, out of breath, drainage of pericardium without obvious hydrops, and check B ultrasound and show: pericardium has no long-pending
Liquid pulls out drainage tube.
Patient 6: Yan, male, and 85 years old.
First visit result: 3 Nian Qianjing physical examination of patient finds pulmonary masses, considers that lung Ca, Bronchofiberscope routine pathology show on right lung
The small thin chest cancer of leaf, at that time without cough and expectoration, no pectoralgia is uncomfortable in chest out of breath, and take traditional Chinese medicine always treatment；Occurred before 2 months out of breath and gradually
Aggravate, look into CT show right lung central type lung Ca with mediastinum, right lung door Lymph Node Metastasis, middle lobe of right lung obstructive atelectasis, pleural effusion,
Superior vena cava is pressurized；The treatment such as hydrothorax drainage, anti-inflammatory is given after being admitted to hospital；But still sense is uncomfortable in chest out of breath, and it is comprehensive to be thought of as superior vena cava compression
Disease is closed, family members are reluctant row superior vena cava Stent, therefore add and treated with Chinese medicine；After taking traditional Chinese herbal decoction 7 days in embodiment 1
Two examine.
Two examine result: patient facial region's oedema, uncomfortable in chest out of breath to be improved.
In addition, it should be noted that, the specific embodiments described in this specification, the shape of parts and components are named
Title etc. can be different, and above content is only to structure of the invention example explanation described in this specification.It is all according to
According to equivalence changes or simple change that the invention patent design structure, feature and principle is done, it is included in this hair
In the protection scope of bright patent.Those skilled in the art can do described specific embodiment various
The mode that the modify or supplement or adopt of various kinds is similar substitutes, and without departing from structure of the invention or surmounts present claims
Range defined in book, is within the scope of protection of the invention.
Claims (5)
1. a kind of Chinese medicinal formulae for treating lung cancer, which is characterized in that the Chinese medicinal formulae of the treatment lung cancer includes according to parts by weight
Following component: it is double dragon 28-32 parts of grass, open country 28-32 parts of Radix Angelicae Sinensis, 18-22 parts of Radix Rehmanniae, 10-14 parts of asparagus fern, 18-22 parts of cordate houttuynia,
10-14 parts of the root bark of tree peony, 10-14 parts of alkanet.
2. the Chinese medicinal formulae for the treatment of lung cancer according to claim 1, which is characterized in that the Chinese medicinal formulae packet of the treatment lung cancer
Include following component according to parts by weight: double 30 parts of dragon grass, wild 30 parts of Radix Angelicae Sinensis, 20 parts of Radix Rehmanniae, 12 parts of asparagus fern, 20 parts of cordate houttuynia,
12 parts of the root bark of tree peony, 12 parts of alkanet.
3. a kind of preparation method of the Chinese medicinal formulae of the treatment lung cancer as described in claim 1-2 any claim, feature
It is, includes the following steps:
S1: weighing double dragon grass, the wild Radix Angelicae Sinensis, Radix Rehmanniae, asparagus fern, cordate houttuynia, the root bark of tree peony, alkanet of specified amount, by weighed medicinal material according to
In secondary investment casserole；
S2: being added clear water in casserole and decoct 1 hour, and the weight of clear water is 10 times of medicinal material total weight；Filtering, collect filter residue and
Filtrate；
S3: clear water being added into filter residue again and decocts 1 hour, and the weight of clear water is 8 times of medicinal material total weight；Filtrate is collected in filtering；
S4: merge the filtrate being obtained by filtration twice, obtain Chinese medicinal formulae.
4. a kind of application method of the Chinese medicinal formulae of the treatment lung cancer as described in claim 1-2 any claim, feature
Be, the dosage of the Chinese medicinal formulae of the treatment lung cancer be it is adult twice daily, each 100-125ml.
5. the application method of the Chinese medicinal formulae for the treatment of lung cancer according to claim 4, which is characterized in that suffer from duration of medication
Person avoids eating seafood and beef and mutton.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910343636.9A CN110025719A (en) | 2019-04-26 | 2019-04-26 | A kind of Chinese medicinal formulae and preparation method thereof for treating lung cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910343636.9A CN110025719A (en) | 2019-04-26 | 2019-04-26 | A kind of Chinese medicinal formulae and preparation method thereof for treating lung cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110025719A true CN110025719A (en) | 2019-07-19 |
Family
ID=67240390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910343636.9A Pending CN110025719A (en) | 2019-04-26 | 2019-04-26 | A kind of Chinese medicinal formulae and preparation method thereof for treating lung cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110025719A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1094957A (en) * | 1993-06-07 | 1994-11-16 | 宫龙章 | Xiaojianwan pill for eliminating hard masses |
| CN101524436A (en) * | 2008-03-06 | 2009-09-09 | 北京中科仁和科技有限公司 | Chinese medicinal composition for treating lung cancer |
| CN103055100A (en) * | 2010-07-21 | 2013-04-24 | 李政育 | Traditional Chinese medicine composition for inhibiting growth of cancer cells and traditional Chinese medicine extract thereof |
-
2019
- 2019-04-26 CN CN201910343636.9A patent/CN110025719A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1094957A (en) * | 1993-06-07 | 1994-11-16 | 宫龙章 | Xiaojianwan pill for eliminating hard masses |
| CN101524436A (en) * | 2008-03-06 | 2009-09-09 | 北京中科仁和科技有限公司 | Chinese medicinal composition for treating lung cancer |
| CN103055100A (en) * | 2010-07-21 | 2013-04-24 | 李政育 | Traditional Chinese medicine composition for inhibiting growth of cancer cells and traditional Chinese medicine extract thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178804B (en) | Chinese medicinal composition for treating perianal eczema and preparation method thereof | |
| CN103520572B (en) | A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof | |
| CN103652360B (en) | Feed for curing pig paratyphus and preparation method thereof | |
| CN103933425A (en) | Traditional Chinese medicine composition for treating lung cancer and preparation method thereof | |
| CN104208245A (en) | Traditional Chinese medicine medicated bath for tinea of feet and hands and preparation method thereof | |
| CN102078569B (en) | Traditional Chinese medicine preparation for treating liver cancer and preparation method thereof | |
| CN103385993B (en) | Chinese medicine preparation for treating gastric ulcer and preparation method thereof | |
| CN103041257B (en) | Chinese materia medica preparation for curing high fever and respiratory tract infection of children | |
| CN104906465A (en) | Traditional Chinese medicine blood-stasis dispersing composition for treating woman chronic pelvic inflammation and preparation method thereof | |
| CN106039109A (en) | Traditional Chinese medicinal liquor for preventing and treating cold dampness accumulation pattern rheumatoid arthritis | |
| CN103495072B (en) | Traditional Chinese medicine composition treating bronchiectasia disease and preparation method thereof | |
| CN110025719A (en) | A kind of Chinese medicinal formulae and preparation method thereof for treating lung cancer | |
| CN105213876A (en) | A kind of medicament for treating insomnia and preparation method thereof | |
| CN103735906A (en) | Chinese herb preparation for treating dry bronchiectasis and preparation method thereof | |
| CN103520427A (en) | Traditional Chinese medicine for treating body-resistance-weak and pathogen-strong type chronic osteomyelitis and preparation method thereof | |
| CN103285161A (en) | Anti-virus traditional Chinese medicinal composition and preparation method thereof | |
| CN107744549A (en) | A kind of medicine for treating toothache and preparation method thereof | |
| CN106109895A (en) | A kind of Chinese medicine composition treating phlegm stagnation fire type chronic pharyngitis and method | |
| CN104873596A (en) | Externally-applied traditional Chinese medicine lotion for treating eczema | |
| CN105597004A (en) | Traditional Chinese medicine combination for treating cancer | |
| CN117379510A (en) | Oral medicinal liquor and preparation method thereof | |
| CN105079310A (en) | Traditional Chinese medicine composition for relieving pain and method for preparing traditional Chinese medicine composition | |
| CN114886959A (en) | Pharmaceutical composition, preparation and application thereof | |
| CN103860976A (en) | Drug composition for treating infantile dermatitis | |
| CN109820965A (en) | It is a kind of to treat lung cancer cough, the Chinese medicine composition of asthma and its application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190719 |